Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,385.00 DKK | +0.04% |
|
-2.77% | -7.20% |
01-31 | Genmab and Pfizer receive positive opinion on Tidvak | FW |
01-24 | Goldman Sachs lowers target price for Genmab to DKK 2,066 (2,425), reiterates neutral - BN | FW |
- Stock Market
- Equities
- GMAB Stock
- Charts Genmab A/S
- Static Chart

MarketScreener is also available in this country: United States.
Switch edition